David H. Zangen

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.

Reversible Mitochondrial Iron Toxicity in Wolfram Syndrome Type 2 Monogenic Diabetes.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 19, 2026

Developing a congenital hyperinsulinism prioritized research agenda: a patient-driven international collaborative research network.

Developing a congenital hyperinsulinism prioritized research agenda: a patient-driven international collaborative research network.

Journal: Frontiers in endocrinology

Published: December 20, 2024

A Novel Homozygous BMP15 Mutation Causes Ovarian Dysgenesis and Primary Amenorrhea.

A Novel Homozygous BMP15 Mutation Causes Ovarian Dysgenesis and Primary Amenorrhea.

Journal: Journal of the Endocrine Society

Published: September 04, 2024

Accurate Prediction of Children's Target Height from Their Mid-Parental Height.

Accurate Prediction of Children's Target Height from Their Mid-Parental Height.

Journal: Children (Basel, Switzerland)

Published: June 08, 2024

Parental awareness and dental health behavior of children with congenital heart disease, with diabetes mellitus, or undergoing anti-cancer treatment, compared to healthy children.

Parental awareness and dental health behavior of children with congenital heart disease, with diabetes mellitus, or undergoing anti-cancer treatment, compared to healthy children.

Journal: Frontiers in oral health

Published: May 19, 2024

Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study.

Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study.

Journal: European journal of endocrinology

Published: September 19, 2023

Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis.

Long-term therapy with CFTR modulators consistently improves glucose metabolism in adolescents and adults with cystic fibrosis.

Journal: Respiratory medicine

Published: July 27, 2023

Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.

Dasiglucagon for the Treatment of Congenital Hyperinsulinism: A Randomized Phase 3 Trial in Infants and Children.

Journal: The Journal of clinical endocrinology and metabolism

Published: July 25, 2023

Growth hormone therapy for children with Duchenne muscular dystrophy and glucocorticoid induced short stature.

Growth hormone therapy for children with Duchenne muscular dystrophy and glucocorticoid induced short stature.

Journal: Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society

Published: May 21, 2023

Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis.

Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis.

Journal: European journal of endocrinology

Published: January 19, 2023

ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes.

ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes.

Journal: Pediatric diabetes

Published: October 24, 2022

Correction to: Early exposures and inherent factors in premature newborns are associated with type 1 diabetes.

Correction to: Early exposures and inherent factors in premature newborns are associated with type 1 diabetes.

Journal: Pediatric research

Published: June 28, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026